Abbas Hajizadeh

Abbas Hajizadeh

Auto-generated profile, based on publicly available information

Abbas Hajizadeh

Biology Research Center, Faculty of Basic Sciences, Imam Hossein University, Tehran, Iran

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 September 2025 in Virulence
Verified
Journal Article
Open access
MAMohadese Amiri
Mohadese Amiri
MGMehdi Golchin
Mehdi Golchin
MMMajid Jamshidian Mojaver
Majid Jamshidian Mojaver
HFHamidreza Farzin
Hamidreza Farzin
AHAbbas Hajizade
Abbas Hajizade
Enterobactin, a high-affinity siderophore produced by Escherichia coli and other enteric pathogens, plays a critical role in bacterial iron acquisition and virulence. By sequestering iron from host environments, enterobactin enables bacterial survival and proliferation, even under iron-limited conditions typical of host tissues. This review explores the biosynthesis and regulation of enterobactin, highlighting its contribution to bacterial pathogenesis and immune evasion. We discuss the potential of targeting enterobactin for the development of live-attenuated vaccines, emphasizing the attenuation of virulence through genetic knockout of enterobactin biosynthesis genes (e.g. entB). Additionally, we examine enterobactin as a promising target for novel antimicrobial strategies, including small-molecule inhibitors and siderophore-based "Trojan horse" antibiotics. Beyond medical applications, we also explore the biotechnological and environmental potential of enterobactin, such as its use in bioremediation and drug delivery systems. Finally, we identify key gaps in current research and propose future directions for harnessing enterobactin to combat bacterial infections and address global health challenges. This review underscores the multifaceted role of enterobactin in bacterial biology and its potential as a cornerstone for innovative therapeutic and biotechnological applications.

23 February 2022 in Molecular Immunology
Verified
Journal Article
Closed access
HAHassan Ardestani
Hassan Ardestani
SNShahram Nazarian
Shahram Nazarian
AHAbbas Hajizadeh
Abbas Hajizadeh
DSDavoud Sadeghi
Davoud Sadeghi
EKEmad Kordbacheh
Emad Kordbacheh

1 April 2020 in Iranian Journal of Toxicology
Verified
Journal Article
Closed access
PDF file
HAHani Keshavarz Alikhani
Hani Keshavarz Alikhani
JZJamil Zargan
Jamil Zargan
ABAli Bidmeshkipour
Ali Bidmeshkipour
AMAshkan Haji Nour Mohammadi
Ashkan Haji Nour Mohammadi
MHMohammad Hosseinpour
Mohammad Hosseinpour
AHAbbas Hajizadeh
Abbas Hajizadeh
Background: The venoms of some scorpions are rich in bioactive components that may be used in the development and discovery of new antibacterial drugs. The venoms have many components, such as neurotoxins, salts, proteins and peptides with therapeutic properties, and can rapidly eliminate a broad range of bacteria. This study evaluated the anti-bacterial activity of Odontobuthus bidentatus’ crude venom against typical Gram-positive and negative bacteria, such as Staphylococcus aureus, Bacillus subtilis, and Escherichia coli. Methods: The antibacterial effects of the crude venom were evaluated using Minimal Inhibitory Concentration (MIC) and MTT assays and its IC50 value was determined, using GraphPad software. Results: The crude venom significantly inhibited the growth of both Gram-positive and negative bacteria. Also the MTT results showed that the crude venom significantly reduced the viability of E. Coli, S. Aureus, and B. Subtilis bacteria compared with that for the controls. The IC50 values of the venom for E.coli, S.aureus, and B.subtilis were 30.19, 17.64, and 24.13 µM, respectively. Conclusion: The findings suggest that the venom of O. bidentatus scorpion has antibacterial properties. Also, our results offer preliminary clues toward the development of new antibacterial agents and new drugs with high therapeutic potentials for use in animals and humans.

1 October 2025 in Journal of Water and Health
Verified
Journal Article
Open access
HKHadis Kalantari
Hadis Kalantari
KIKhosro Issazadeh
Khosro Issazadeh
AHAbbas Hajizade
Abbas Hajizade
MGMohammad Faezi Ghasemi
Mohammad Faezi Ghasemi
This study characterizes vancomycin-resistant Enterococci (VRE) in Iran's Anzali Lagoon recreational waters through analysis of 268 samples collected seasonally (2019). Culture and PCR methods identified Enterococcus in 57.5% (154/268) of samples, with 40.3% (62/154) showing vancomycin resistance. Resistance gene profiling revealed vanA and vanH predominance (56.5% each, 35/62), demonstrating complete co-occurrence, while vanB was rare (3.2%, 2/62) and vanC absent. Virulence factors displayed divergent prevalence: esp (62.9%, 39/62) exceeded clinical isolate rates, whereas hyl (3.2%, 2/62) was uncommon. Biofilm assays showed VRE isolates formed significantly denser biofilms than susceptible strains (2.3-fold higher OD570, p < 0.001), with esp-positive isolates exhibiting the strongest biofilm production. These findings demonstrate that recreational waters harbor VRE populations with: (1) elevated esp prevalence suggesting environmental selection pressures, and (2) enhanced biofilm capacity promoting persistence. The 100% vanA-vanH co-occurrence and 62.9% esp frequency surpass WHO risk thresholds for recreational waters, indicating need for revised monitoring protocols. This study provides the first evidence of aquatic-specific VRE genotypes in the region and their potential public health impacts through resistance gene dissemination and waterborne exposure risks.